Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.
The Scientist
Most Recent
Advances in genomics and cancer biology will alter the design of human cancer studies.
Contributors
| April 1, 2013
Meet some of the people featured in the April 2013 issue of The Scientist.
A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.
Research into how the brain suffers as a result of chemotherapy is revealing potential avenues for ameliorating cognitive decline.
Oncologist Jane C. Wright and physics Nobel-winner Donald Glaser have died.
A chemotherapy medication designed to kill cancer may prevent neuronal death after stroke, according to a study in mice.
Starvation paired with cancer drugs slowed or stopped unchecked cell growth in yeast and mouse models of cancer, outpacing or matching the isolated effects of chemo.
Irradiated sperm of young male mice induce mutations in eggs upon fertilization, a phenomenon that may pose risks for the children of cancer survivors.
Proteins and nanoparticles that talk in order to more efficiently locate and treat tumors could reduce collateral damage to healthy tissues
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
